English

Pharmaceutical companies

World

Counterfeit medicine trade: how online pharmacies are selling deadly fake painkillers across Europe

ADVERTISEMENT

ADVERTISEMENT

Business

US launches trade probe into Germany over medicine prices

Washington has accused Berlin of artificially capping medicine prices while the US market pays significantly more for identical products. If a pending trade investigation finds Germany’s policies unfair, the United States could hit back with punitive tariffs.

Health news

Drug monopoly extension splits EU ministers in Biotech Act debate

EU health ministers split over a proposal to give certain innovative medicines an extra year of market protection, with EU Health Commissioner arguing the incentive is needed to keep biotech investment in Europe. Incoming Irish presidency, in the meantime, says it will work as quickly as possible.

Health news

EU health chief to probe effects of Trump’s drug pricing push

The EU health ministers have tasked the European Health Commissioner to assess the impact of the US’ most-favourite-nation policy on the bloc.

Health news

Where do Europeans wait longest for new medicines?

Access to new medicines still varies sharply across Europe, with waits ranging from months to more than three years, according to the European Federation of Pharmaceutical Industries and Associations.

ADVERTISEMENT

The Big Question

The rising threat of antimicrobial resistance and its economic toll

More people are expected to die every year from superbugs than cancer by 2050. Antibiotic resistance is ‘a major threat’ to our health and economy, according to Japanese pharma experts.

Health news

Roche gets European approval for Alzheimer’s diagnosis blood test

Swiss pharmaceutical company Roche has received European approval for a blood test that can detect and rule out Alzheimer’s disease, offering a simpler and less invasive alternative to current diagnostic methods.

Health news

OpenAI launches life science AI model. Here’s everything to know

The GPT-Rosalind model is designed to accelerate biological research and drug discovery.

Health news

Novo Nordisk joins forces with OpenAI to fast-track drug research

Danish pharma company Novo Nordisk has announced a partnership with OpenAI to apply artificial intelligence across its drug development process.

Health news

Eli Lilly bets on AI-powered drugs in new deal with Insilico Medicine

Eli Lilly has partnered with AI biotech Insilico Medicine for exclusive global rights to develop and commercialise medicines designed entirely by artificial intelligence.

Health news

Antibiotic pipeline shrinks as drug-resistance rises, report finds

The antibiotic pipeline has shrunk 35 percent in five years, falling behind growing antimicrobial resistance worldwide, according to a new report.

Health news

New oral pill outperforms weight-loss alternatives, trial finds

Eli Lilly’s new oral pill, orforglipron, led to up to 8% weight loss in clinical trials, outperforming existing oral semaglutide alternatives.

Health news

Why weight loss drugs aren't Denmark's trump card in Greenland dispute

Novo Nordisk, the Danish manufacturer of weight-loss drugs Ozempic and Wegovy, has a large market share in the US. But it's not enough to put pressure on US President Donald Trump's administration during Greenland talks, experts say.

Health news

Could green inhalers cut health care’s climate footprint?

As climate change worsens respiratory diseases, doctors and drugmakers are exploring earlier diagnosis and low-carbon inhalers to cut emissions from care and protect patients.

Health news

New gonorrhoea treatment could help beat drug-resistant infections

A new single-dose treatment for gonorrhoea, expected to be approved in the coming days, could be the key to tackling the infection amid rising antibiotic resistance.

Health news

EU unveils new pharma package to boost industry

The European Union has agreed on new pharmaceutical rules introducing new incentives to boost the pharmaceutical industry amid accessibility concerns.

Business

Pharma market shake-up: Bayer jumps, Novo Nordisk sinks 10%

Shares of Danish pharmaceutical giant Novo Nordisk fell sharply after its Alzheimer's drug failed to slow progression of the disease in a trial. Meanwhile, Germany's Bayer said their stroke-prevention drug showed positive results, pushing the share price through the roof.